Authors:
KARETNYI YV
FAVOROV MO
KHUDYAKOVA NS
BARSHANI S
DAGAN R
FIELDS HA
MENDELSON E
Citation: Yv. Karetnyi et al., POPULATIONS WITH HIGH PREVALENCE OF ANTIBODY AGAINST HEPATITIS-E VIRUS IN ISRAEL, Clinical and diagnostic virology, 6(1), 1996, pp. 73-76
Citation: Sj. Naides et al., PARVOVIRUS B19 AS AN ETIOLOGIC AGENT OF FULMINANT NON-A, NON-B, NON-C, NON-E HEPATITIS (HNA-E) - EVIDENCE FOR PRODUCTIVE VIRAL-INFECTION, The FASEB journal, 10(6), 1996, pp. 26-26
Authors:
NAIDES SJ
KARETNYI YV
MARKIN S
LANGNAS AN
Citation: Sj. Naides et al., HUMAN PARVOVIRUS B19 HEPATOTROPIC GENETIC VARIANT(S) AS AGENT(S) OF NON-A, NON-B, NON-C, NON-E FULMINANT LIVER-FAILURE (NA-EFLF), Arthritis and rheumatism, 39(9), 1996, pp. 717-717
Authors:
LINDER N
KARETNYI YV
KUINT J
MENDELSON E
DAGAN R
Citation: N. Linder et al., SYMPTOMATIC HEPATITIS-A VIRUS-INFECTION DURING THE FIRST YEAR OF LIFE, The Pediatric infectious disease journal, 14(7), 1995, pp. 628-629
Authors:
KARETNYI YV
MENDELSON E
SHLYAKHOV E
RUBINSTEIN E
GOLUBEV N
LEVIN R
SANDLER M
SCHREIBER M
RUBINSTEIN U
SHIF I
HANDSHER R
VARSANO N
MODAN B
Citation: Yv. Karetnyi et al., PREVALENCE OF ANTIBODIES AGAINST HEPATITIS-A VIRUS AMONG NEW IMMIGRANTS IN ISRAEL, Journal of medical virology, 46(1), 1995, pp. 61-65